Document Detail


Onychomycosis. Baseline results of an observational study.
MedLine Citation:
PMID:  9397656     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The investigators present an analysis of baseline quality-of-life and patient-management approaches from an observational study of 150 patients being treated by podiatric physicians and dermatologists for onychomycosis. The majority (73%) made the initial office visit specifically because of their onychomycosis. Both men and women indicated that they had substantial physical discomfort as well as concerns related to appearance. Women reported significantly more problems than did men as a result of their onychomycosis. Physicians reported that 54% of patients suffered from toenail discomfort, 36% had pain while walking, 40% reported that their condition limited wearing of shoes, and 67% were embarrassed by the condition. The results of this study suggest that the treatment approach of podiatric physicians is more likely to address the palliative concerns of patients with onychomycosis, while the approach of dermatologists is more likely to attempt a definitive cure.
Authors:
J R Schein; D Gause; D M Stier; D P Lubeck; M M Bates; R Fisk
Related Documents :
23104126 - Semicircular canal, saccular and utricular function in patients with bilateral vestibul...
15328676 - Quality of life in common variable immunodeficiency requiring intravenous immunoglobuli...
11109056 - Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-...
24015376 - Prostanoids but not oral therapies improve right ventricular function in pulmonary arte...
8102226 - Examination of hla-dr4 as a severity marker for rheumatoid arthritis in greek patients.
24834226 - Gluten associated dyspepsia; serology and histological characteristics.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Podiatric Medical Association     Volume:  87     ISSN:  8750-7315     ISO Abbreviation:  J Am Podiatr Med Assoc     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1997-12-24     Completed Date:  1997-12-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8501423     Medline TA:  J Am Podiatr Med Assoc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  512-9     Citation Subset:  IM    
Affiliation:
Novartis Pharmaceuticals Corp, East Hanover, NJ 07936, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Antifungal Agents / therapeutic use
Dermatology
Female
Foot Dermatoses
Hand Dermatoses
Humans
Longitudinal Studies
Male
Middle Aged
Onychomycosis / complications,  diagnosis,  therapy*
Podiatry
Quality of Life*
Chemical
Reg. No./Substance:
0/Antifungal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of onychomycosis on quality of life.
Next Document:  Oral treatment options for onychomycosis.